Rare diseases
Investigational molecules
Locations
780 Brannan Street, 94103-4919, United States
Olema Pharmaceuticals Inc. focuses on ER+, HER2- advanced breast cancer, including metastatic breast cancer and disease after endocrine therapy and CDK 4/6 inhibitor treatment. Its clinical research is centered on hormone receptor-driven disease and treatment settings where resistance to standard endocrine approaches is a major concern.
The sponsor’s studies include both monotherapy and combination strategies aimed at improving disease control in advanced breast cancer populations.
Olema Pharmaceuticals Inc. runs clinical trials in conditions such as Breast cancer metastatic, Hormone receptor positive breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
